Form D · Biotechnology
Intellistem, Inc.
San Francisco, CA · CIK 0002019882
Offering snapshot reported Jul 18, 2024 · SEC filing
- Reported sold
- Yet to sell Offering amount: $5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 18, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Apr 18, 2024 | Initial | $1,200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-519159
Source: Form D, filed Jul 18, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Riam Shammaa | Director, Promoter |
| William St. John | Director, Executive, Promoter |
| Martin Wilhelm | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
440 Davis Court #901
San Francisco, CA, 94111
San Francisco, CA, 94111